Home › Melanoma › Michigan › Detroit

Pag-aaral pangklinika para sa Melanoma sa Detroit, MI

Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Detroit. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Henry Ford Hospital, Detroit
Henry Ford Health Saint John Hospital, Detroit

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Nagre-recruitPhase 3

Henry Ford Cancer Institute/Henry Ford Health System, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06246916

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Nagre-recruitPhase 1/2

Wayne State University - Barbara Ann Karmanos Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07287917

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Nagre-recruitPhase 1/2

Brigitte Harris Cancer Pavilion BHCP, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07070232

Project: Every Child for Younger Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Michigan, Detroit

Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Karmanos Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Nagre-recruitPhase 1/2

Henry Ford Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site 129, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

A Beta-only IL-2 ImmunoTherapY Study

Nagre-recruitPhase 1/2

Karmanos Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2025 · NCT05086692

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Henry Ford Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2025 · NCT05970497

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Nagre-recruitPhase 1/2

Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2025 · NCT05669430

Pag-aaral para sa Melanoma sa ibang lungsod

Iba pang pag-aaral sa Detroit

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.